Viral Hepatitis A Treatment
There is no cure for hepatitis A. The therapy for hepatitis A is supportive as the illness generally resolves on its own. Liver failure due to hepatitis A is very rare.
Treatment for hepatitis A may include:
- Medications to control nausea and vomiting:
- Acetaminophen may be used for pain and fever control:
- Oral rehydration therapy:
- Intravenous rehydration may be necessary if vomiting is severe
- Liver disease diet:
- Avoidance of medications that could accumulate in the liver
- Antihistamine for itching:
- Immune globulins: used for post exposure prophylaxis
- Immune globulin, intramuscular (BayGam 15-18%)
- Vitamin B supplements:
- Vitamin B1 (thiamine)
- Vitamin B2 (riboflavin)
- Vitamin B3 (niacin)
- Vitamin B5 (pantothenic acid)
- Vitamin B6 (pyridoxine)
- Vitamin B12 (cobalamin)
- Hepatitis B immunization
Viral Hepatitis A Questions For Doctor
The following are some important questions to ask before and after the treatment of hepatitis A.
Questions to ask before treatment:
- What are my treatment options?
- What are the risks associated with treatment?
- Do I need to stay in the hospital?
- How long will I be in the hospital?
- Am I contagious?
- For how long?
- What are the complications I should watch for?
- How long will I be on medication?
- What are the potential side effects of my medication?
- Does my medication interact with nonprescription medicines or supplements?
- Should I take my medication with food?
Questions to ask after treatment:
- Do I need to change my diet?
- Are there any medications or supplements I should avoid?
- When can I resume my normal activities?
- When can I return to work?
- How do I avoid passing the infection to others?
- What else can I do to reduce my risk for complications?
- What else can I do to reduce my risk for liver disease?
- How often will I need to see my doctor for checkups?
- What local support and other resources are available?
Viral Hepatitis A Specialist
Continue to Viral Hepatitis A Home Care
- Centers for Disease Control and Prevention (CDC). Positive test results for acute hepatitis A virus infection among persons with no recent history of acute hepatitis--United States, 2002-2004. MMWR Morb Mortal Wkly Rep. 2005 May 13;54(18):453-6. 
- Jacobsen KH, Koopman JS. Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol Infect. 2004 Dec;132(6):1005-22. 
- Murdoch DL, Goa K, Figgitt DP. Combined hepatitis A and B vaccines: a review of their immunogenicity and tolerability. Drugs. 2003;63(23):2625-49. 
- Oncu S, Oncu S, Sakarya S. Hepatitis A and B seropositivity among medical students. Health Policy. 2005 Sep 28;74(1):39-45. 
- Saab S, Lee C, Shpaner A, Ibrahim AB. Seroepidemiology of hepatitis A in patients with chronic liver disease. J Viral Hepat. 2005 Jan;12(1):101-5. 
- Wasley A, Samandari T, Bell BP. Incidence of hepatitis A in the United States in the era of vaccination. JAMA. 2005 Jul 13;294(2):194-201.